By Charles Bankhead
Source Medpagetoday
Individuals screened for Epstein-Barr virus (EBV) infection had a significantly lower risk of nasopharyngeal cancer (NPC) mortality, a large randomized study from China showed.
Screened individuals had a 30% reduction in cancer-specific mortality over a 12-year period versus similar individuals who were not screened, reported Su-Mei Cao, MD, PhD, of Sun Yat-sen University Cancer Center in Guangzhou, China, and co-authors. Patients ages 50 and older derived the greatest benefit.
The findings added to previous evidence that screening improves NPC detection and survival, Cao and colleagues wrote in the Journal of Clinical Oncologyopens in a new tab or window. EBV is a necessary cause for undifferentiated carcinoma, which accounts for approximately 95% of NPCs in endemic regions, they pointed out.
Read more https://www.medpagetoday.com/hematologyoncology/othercancers/112272